Maternal and Infant Cord Blood Monosaccharide Content

This study has been completed.
Sponsor:
Collaborators:
USDA Beltsville Human Nutrition Research Center
University of Arkansas
Information provided by:
Arkansas Children's Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00783770
First received: October 31, 2008
Last updated: May 16, 2011
Last verified: May 2011

October 31, 2008
May 16, 2011
July 2005
March 2007   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00783770 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Maternal and Infant Cord Blood Monosaccharide Content
Comparison of Monosaccharide Content of Maternal and Umbilical Venous Cord Blood in Term and Preterm Pregnancies

Mother's breast milk provides many benefits to babies with regard to development and improved health. We believe the simple sugars which make up these complex sugars in breast milk and are also found in the brain may be critical to normal brain development in term and preterm infants.

Babies are exposed to these sugars by placental transport during pregnancy and through mother's breast milk after they are born. For the preterm infant, we do not know if breast milk gives enough of these sugars compared to what the baby gets during pregnancy.

A maternal blood sample and blood samples from the baby's umbilical cord will provide us with background information for developing a supplement of special sugars that can be added to infant formulas to provide the amount that the baby usually gets during pregnancy and from breast milk.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Retention:   Samples Without DNA
Description:

plasma will be stored

Non-Probability Sample

Twenty-four generally healthy mother-infant pairs.

Pregnancy
Not Provided
  • 30-33 weeks
    mother infant pairs with gestation of 30-33 weeks
  • 34-37 weeks
    mother infant pairs with gestation of 34-37 weeks
  • 38-42 weeks
    mother infant pairs with gestation of 38-42 weeks
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
48
Not Provided
March 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy mothers with ages ranging from 18 to 35 yrs
  • Delivered infants appropriate weight for gestational age (between 10% and 90%)

Exclusion Criteria:

  • Maternal history of smoking, alcohol or drug use
Female
18 Years to 35 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00783770
31247
No
Joanne S. Szabo, M.D., University of Arkansas for Medical Sciences
Arkansas Children's Hospital Research Institute
  • USDA Beltsville Human Nutrition Research Center
  • University of Arkansas
Not Provided
Arkansas Children's Hospital Research Institute
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP